Norma Tavakoli

Researcher leads newborn screening program testing for more than 40 genetic disorders

The World Within Reach
Contact the Office of Media Relations at (518) 956-8150
 

Norma Tavakoli

Assistant Professor
School of Public Health
Department: Biomedical Sciences

Expertise:
Newborn screening; genetic disorders; molecular detection techniques; cystic fibrosis

Campus phone: (518) 402-5210
Campus email: ntavakoli@albany.edu

Biography:

Assistant Professor of Biomedical Sciences Norma Tavakoli leads the Newborn Screening Program at the Wadsworth Center.

The Newborn Screening Program at Wadsworth Center tests for over 40 genetic disorders in newborns. Infants who have one of several rare genetic disorders and infants who have been exposed to HIV are identified promptly; with medical treatment serious disease can often be prevented. One of the tests is molecular detection of cystic fibrosis (CF) by screening for a mutation panel in the CFTR gene. Certain mutations in this gene cause severe phenotype and are well-defined. The gold standard for a CF diagnosis is a sweat chloride test.

Screening has uncovered individuals whose sweat chloride values are above normal, but no other CF symptoms are identified. The program's aim is to determine if other variants in the CFTR gene correlate with these abnormal sweat chloride levels. This will be carried out by searching for other variants in the CFTR gene and also modifier genes (other genes that may modulate sweat chloride values).

A different newborn screening test that is provided detects Krabbe disease, which is caused by the deficient activity of galactosylceramidase (GALC gene). Expression studies to determine the enzyme activity resulting from mutations in the GALC gene compared to activities present when the normal gene is expressed will be performed in order to better understand and perhaps predict the clinical presentation, evolution and prognosis of the disease.